Evidence map›Paper›PMID 33818669›Full record

ArticleJournal of bioenergetics and biomembranes2021

Molecular modeling for potential cathepsin L inhibitor identification as new anti-photoaging agents from tropical medicinal plants.

Sophi Damayanti, Nabilla Rizkia Fabelle, Wipawadee Yooin, Muhamad Insanu, Supat Jiranusornkul, Pathomwat Wongrattanakamon

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of bioenergetics and biomembranes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sophi DamayantiPharmacochemistry Research Group, School of Pharmacy, Bandung Institute of Technology, Jalan Ganesa 10, Bandung, 40132, Indonesia.
Nabilla Rizkia FabellePharmacochemistry Research Group, School of Pharmacy, Bandung Institute of Technology, Jalan Ganesa 10, Bandung, 40132, Indonesia.
Wipawadee YooinLaboratory for Molecular Design and Simulation (LMDS), Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
Muhamad InsanuPharmaceutical Biology Research Group, School of Pharmacy, Bandung Institute of Technology, Jalan Ganesa 10, Bandung, 40132, Indonesia.
Supat JiranusornkulLaboratory for Molecular Design and Simulation (LMDS), Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand. supat.jira@cmu.ac.th.
Pathomwat WongrattanakamonLaboratory for Molecular Design and Simulation (LMDS), Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand. pathomwat@yahoo.com.ORCID http://orcid.org/0000-0001-6619-1557

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ultraviolet exposure can cause photoaging toward the human skin which is begun by the inflammation on the exposure area, also resulting in activation of a degradative enzyme cathepsin L. This enzyme is one of the interesting novel therapeutic targets for antiaging agents. Three plants, named Kleinhovia hospita, Aleurites moluccana, and Centella asiatica, are well-known in the tropical region as anti-inflammatory herbs. The aims of this study were to predict the antiaging activity of the 31 compounds from these plants via inhibition of cathepsin L. All compounds were minimized their energies and then used in molecular docking. After that, molecular dynamics (MD) simulation was employed for the 5 candidate ligands and the positive control; schinol. Interaction analysis results of the pre-MD and post-MD simulation structures were obtained. Furthermore, a toxicity test was performed using ADMET Predictor 7.1. Based on the molecular docking and the MD simulation results, kleinhospitine A, β-amyrin, and castiliferol exhibited lower binding free energy than schinol (-27.0925, -28.6813, -26.0037 kcal/mol) and also had interactions with the S´ region binding site. The toxicity test indicated that β-amyrin is the most potential candidate since it exhibited the lowest binding energy and the high safety level.

Indexed as

Cathepsin LHumansModels, MolecularMolecular Docking SimulationPlants, MedicinalCathepsin LAntiagingCathepsin LHerbal compoundsMolecular dockingMolecular dynamics simulationToxicity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.